Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications. [electronic resource]
Producer: 20100121Description: 61-8 p. digitalISSN:- 1524-4563
- Adolescent
- Adult
- Aged
- Antihypertensive Agents -- adverse effects
- Atenolol -- adverse effects
- Diabetes Mellitus -- chemically induced
- Drug Therapy, Combination
- Fasting -- blood
- Female
- Humans
- Hydrochlorothiazide -- adverse effects
- Hyperglycemia -- blood
- Hypertension -- blood
- Hypertriglyceridemia -- blood
- Hyperuricemia -- chemically induced
- Lipoproteins, HDL -- blood
- Male
- Metabolic Diseases -- chemically induced
- Middle Aged
- Obesity, Abdominal -- physiopathology
- Outcome Assessment, Health Care -- statistics & numerical data
- Young Adult
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.